Peptide Therapy Marketing · Tirzepatide

Tirzepatide Patient Lead Generation for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

Tirzepatide has become the premium alternative to Semaglutide for patients who want faster or greater weight loss outcomes. Most of the patients searching for it have either plateaued on Semaglutide or read enough about the dual GLP-1 and GIP mechanism to want the newer option. PeptideLeads delivers these patients to your clinic for $50 per qualified lead. No retainer, we cover all ad spend, and founder Tamerlan Musayev built the system to handle the fastest-growing weight loss category in peptide therapy.

The Market Context

Tirzepatide search volume has exploded since 2023 and continues climbing. Monthly searches across Tirzepatide, Mounjaro, and Zepbound related terms exceed 1.5 million in the United States. The patient profile skews slightly higher-income than Semaglutide because the compounded pricing is typically higher. The core segment is women 35 to 60 who have tried Semaglutide and either want to switch or want to start with the newer option directly. Men 30 to 55 are a growing segment as well.

Why This Works

Tirzepatide protocols run 6 to 12 months and patients often stay on maintenance protocols afterward. First-year revenue per patient typically lands between $4,000 and $9,000 depending on pricing model. At $50 per lead and 25 to 35 percent close rates, cost of acquisition is well within profitable territory.

How Our Process Works

We run paid campaigns on Meta and Google with creative specifically positioned around Tirzepatide outcomes. Qualification captures BMI, prior GLP-1 experience, state, and start timeline. Phone verified before delivery. We cover all ad spend. You pay $50 per qualified lead.

What Makes Us Different

Tirzepatide ads require careful language to stay compliant with platform rules around weight loss claims. We have developed copy patterns that work at scale. General agencies struggle with this balance and often see their ad accounts restricted.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

If your clinic offers Tirzepatide and wants qualified patients at a flat $50 rate, let's talk.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

How does Tirzepatide demand compare to Semaglutide?

Tirzepatide is growing faster percentage-wise but total volume still favors Semaglutide. Both categories are strong.

What does each lead include?

Full contact info, BMI, prior GLP-1 history, state, and start timeline.

Do patients want to switch from Semaglutide?

Many do. Our qualification captures that so your intake team is prepared.

Is ad spend covered?

Yes.

Is there a retainer?

No.